Coronavirus Notebook: EMA Hones In On COVID-19 Activities, Russia’s Sputnik V Launches In India

A new study shows that the immune response to Pfizer/BioNTech’s Comirnaty in elderly people is 3.5-fold greater when the second dose is given after 12 weeks rather than three. The WHO has OKd the emergency use of a Chinese vaccine.